Article Information
History
- July 30, 2020.
Article Versions
- Version 1 (July 25, 2020 - 21:48).
- You are currently viewing Version 2 of this article (July 30, 2020 - 17:03).
- Version 3 (January 5, 2021 - 16:48).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Bojan F. Hörnich1,
- Anna K. Großkopf1,
- Sarah Schlagowski1,
- Matthias Tenbusch2,
- Frank Neipel2 and
- Alexander S. Hahn1,*
- 1Nachwuchsgruppe Herpesviren, Abteilung Infektionsbiologie, Deutsches Primatenzentrum – Leibniz-Institut für Primatenforschung, Göttingen, Germany
- 2Virologisches Institut, Universitätsklinikum Erlangen, Erlangen, Germany
- ↵*Correspondence to: ahahn{at}dpz.eu
Posted July 30, 2020.
SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation and are not inhibited by Bromhexine
